Resonance Health
Resonance Health is a MedTech company specializing in non-invasive medical imaging analysis, particularly in iron overload and liver disease management. Their portfolio includes post-MRI analysis tools like FerriScan and HepaFatScan, providing quantitative calculations and evaluations essential for disease management and clinical trials.
Short position
Resonance Health (ASX:RHT) has 0.02% of its shares on issue reported as short positions as of 25 Sept 2026, or about 71,783 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.23% in February 2019. RHT is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Resonance Health (RHT) short interest history
RHT Short Interest History
- 30-day change
- +0.01pp
- 90-day change
- +0.01pp
- 1-year change
- +0.01pp
- All-time high
- 0.23% (February 2019)
- All-time low
- 0.00% (February 2014)
Is RHT heavily shorted?
Not especially: 0.02% short interest is modest by ASX standards, ranking #565 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has RHT's short interest changed recently?
Over the past 30 days Resonance Health's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.02% of shares on issue.
What is the highest RHT's short interest has been?
Since 2014, Resonance Health's short interest peaked at 0.23% in February 2019 and bottomed at 0.00% in February 2014.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2014. See our methodology.